Peptide record

TPDB06964

Antibacterial Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06964
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 13-aa standard-residue multi-activity (Antibacterial and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
IKKWLSKIKKLLK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C80H144N20O15
ARNDCEQGHMFPTYV
K
1626.15
11.21
6
0
6
+6
0.75
-0.362
150.00
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
5500
3.38
1
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
2
I
3
L
6
K
0
M
0
F
0
P
1
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 2 L: 3 K: 6 M: 0 F: 0 P: 0 S: 1 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
13 reviewed residue count
C80H144N20O15 sequence-only estimate (linear, free termini)
1626.15 sequence-only estimate (linear, free termini)
11.21 sequence-only estimate (linear, free termini)
+6 sequence-only estimate (linear, free termini)
0.75 sequence-only estimate (linear, free termini)
-0.362 sequence-only estimate (linear, free termini)
Evidence Records 11 records
Evidence 1 Activity

Activity

MIC
Antibacterial
1.56 µM

Target

Staphylococcus aureus

Source & Reference

NA

Other

active against Gram+ S. aureus (MIC 1.56 uM), E. faecalis (MIC 2.50 uM), E. faecium (MIC 1.56 uM), B. cereus (MIC 1.56 uM), S. epiderm
Evidence 2 Activity

Activity

MIC
Antibacterial
2.50 µM

Target

Enterococcus faecalis

Source & Reference

NA

Other

active against Gram+ S. aureus (MIC 1.56 uM), E. faecalis (MIC 2.50 uM), E. faecium (MIC 1.56 uM), B. cereus (MIC 1.56 uM), S. epidermidis (MIC 1.56 uM), Gram- E
Evidence 3 Activity

Activity

MIC
Antibacterial
1.56 µM

Target

E. faecium

Source & Reference

NA

Other

active against Gram+ S. aureus (MIC 1.56 uM), E. faecalis (MIC 2.50 uM), E. faecium (MIC 1.56 uM), B. cereus (MIC 1.56 uM), S. epidermidis (MIC 1.56 uM), Gram- E. coli (MIC 6.25 uM), P. a
Evidence 4 Activity

Activity

MIC
Antibacterial
1.56 µM

Target

B. cereus

Source & Reference

NA

Other

ainst Gram+ S. aureus (MIC 1.56 uM), E. faecalis (MIC 2.50 uM), E. faecium (MIC 1.56 uM), B. cereus (MIC 1.56 uM), S. epidermidis (MIC 1.56 uM), Gram- E. coli (MIC 6.25 uM), P. aeruginosa (MIC 3.13 uM),
Evidence 5 Activity

Activity

MIC
Antibacterial
1.56 µM

Target

Staphylococcus epidermidis

Source & Reference

NA

Other

C 1.56 uM), E. faecalis (MIC 2.50 uM), E. faecium (MIC 1.56 uM), B. cereus (MIC 1.56 uM), S. epidermidis (MIC 1.56 uM), Gram- E. coli (MIC 6.25 uM), P. aeruginosa (MIC 3.13 uM), K. pneumoniae (MIC 50 uM), E.
Evidence 6 Activity

Activity

MIC
Antibacterial
6.25 µM

Target

Escherichia coli

Source & Reference

NA

Other

), E. faecium (MIC 1.56 uM), B. cereus (MIC 1.56 uM), S. epidermidis (MIC 1.56 uM), Gram- E. coli (MIC 6.25 uM), P. aeruginosa (MIC 3.13 uM), K. pneumoniae (MIC 50 uM), E. cloacae (MIC 12.5 uM), and P.
Evidence 7 Activity

Activity

MIC
Antibacterial
3.13 µM

Target

Pseudomonas aeruginosa

Source & Reference

NA

Other

uM), B. cereus (MIC 1.56 uM), S. epidermidis (MIC 1.56 uM), Gram- E. coli (MIC 6.25 uM), P. aeruginosa (MIC 3.13 uM), K. pneumoniae (MIC 50 uM), E. cloacae (MIC 12.5 uM), and P. mirabilis (MIC 12.5 uM).
Evidence 8 Activity

Activity

MIC
Antibacterial
50 µM

Target

Klebsiella pneumoniae

Source & Reference

NA

Other

, S. epidermidis (MIC 1.56 uM), Gram- E. coli (MIC 6.25 uM), P. aeruginosa (MIC 3.13 uM), K. pneumoniae (MIC 50 uM), E. cloacae (MIC 12.5 uM), and P. mirabilis (MIC 12.5 uM).
Evidence 9 Activity

Activity

MIC
Antibacterial
12.5 µM

Target

Enterobacter cloacae

Source & Reference

NA

Other

uM), Gram- E. coli (MIC 6.25 uM), P. aeruginosa (MIC 3.13 uM), K. pneumoniae (MIC 50 uM), E. cloacae (MIC 12.5 uM), and P. mirabilis (MIC 12.5 uM).
Evidence 10 Activity

Activity

MIC
Antibacterial
12.5 µM

Target

P. mirabilis

Source & Reference

NA

Other

M), P. aeruginosa (MIC 3.13 uM), K. pneumoniae (MIC 50 uM), E. cloacae (MIC 12.5 uM), and P. mirabilis (MIC 12.5 uM).
Evidence 11 Activity

Activity

50% Hemolysis
Toxicity
>500 µM
Hemolytic Cytotoxic
50% Hemolysis | >500 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action. | J Appl Microbiol | 2013